These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37188251)

  • 1. Novel quinoline/thiazinan-4-one hybrids; design, synthesis, and molecular docking studies as potential anti-bacterial candidates against MRSA.
    Mohamed AH; Mostafa SM; Aly AA; Hassan AA; Osman EM; Nayl AA; Brown AB; Abdelhafez EMN
    RSC Adv; 2023 May; 13(21):14631-14640. PubMed ID: 37188251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, molecular docking study, and antibacterial evaluation of some new fluoroquinolone analogues bearing a quinazolinone moiety.
    Norouzbahari M; Salarinejad S; Güran M; Şanlıtürk G; Emamgholipour Z; Bijanzadeh HR; Toolabi M; Foroumadi A
    Daru; 2020 Dec; 28(2):661-672. PubMed ID: 33030668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel 1,2,4-oxadiazole-chalcone/oxime hybrids as potential antibacterial DNA gyrase inhibitors: Design, synthesis, ADMET prediction and molecular docking study.
    Ibrahim TS; Almalki AJ; Moustafa AH; Allam RM; Abuo-Rahma GEA; El Subbagh HI; Mohamed MFA
    Bioorg Chem; 2021 Jun; 111():104885. PubMed ID: 33838559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-thiadiazole-4-hydroxy-2-quinolone-3-carboxamides bearing heteroaromatic rings as novel antibacterial agents: Design, synthesis, biological evaluation and target identification.
    Xue W; Li X; Ma G; Zhang H; Chen Y; Kirchmair J; Xia J; Wu S
    Eur J Med Chem; 2020 Feb; 188():112022. PubMed ID: 31901744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential Fluorinated Anti-MRSA Thiazolidinone Derivatives with Antibacterial, Antitubercular Activity and Molecular Docking Studies.
    Kumar V; Shetty P; H S A; Chandra K S; Ramu R; Patil SM; Baliga A; Rai VM; M SS; Udupi V; Poojary V; Poojary B
    Chem Biodivers; 2022 Feb; 19(2):e202100532. PubMed ID: 34929067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of novel 1,2-bis-quinolinyl-1,4-naphthoquinones: ERK2 inhibition, cytotoxicity and molecular docking studies.
    Aly AA; El-Sheref EM; Bakheet MEM; Mourad MAE; Brown AB; Bräse S; Nieger M; Ibrahim MAA
    Bioorg Chem; 2018 Dec; 81():700-712. PubMed ID: 30268050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, biological evaluation and molecular docking studies of novel quinazolinones as antitubercular and antimicrobial agents.
    Kumar Pandey S; Yadava U; Upadhyay A; Sharma ML
    Bioorg Chem; 2021 Mar; 108():104611. PubMed ID: 33484939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthetic approach,
    Abdelmonsef AH; Omar M; Rashdan HRM; Taha MM; Abobakr AM
    RSC Adv; 2022 Dec; 13(1):292-308. PubMed ID: 36605637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, identification and in vitro biological evaluation of some novel quinoline incorporated 1,3-thiazinan-4-one derivatives.
    Umamatheswari S; Sankar C
    Bioorg Med Chem Lett; 2017 Feb; 27(3):695-699. PubMed ID: 28065567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of ciprofloxacin-sulfonamide hybrids to manipulate ciprofloxacin pharmacological qualities: Potency and side effects.
    Ibrahim NM; Fahim SH; Hassan M; Farag AE; Georgey HH
    Eur J Med Chem; 2022 Jan; 228():114021. PubMed ID: 34871841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of hybrid quinolone-based quaternary ammonium antibacterial agents.
    Fedorowicz J; Sączewski J; Konopacka A; Waleron K; Lejnowski D; Ciura K; Tomašič T; Skok Ž; Savijoki K; Morawska M; Gilbert-Girard S; Fallarero A
    Eur J Med Chem; 2019 Oct; 179():576-590. PubMed ID: 31279292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyridine coupled pyrazole analogues as lethal weapon against MRSA: An in-vitro and in-silico approach.
    Nanjundaswamy S; Jayashankar J; Renganathan RRA; Karthik CS; Mallesha L; Mallu P; Rai VR
    Microb Pathog; 2022 May; 166():105508. PubMed ID: 35364241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thiazolidine-2,4-dione-linked ciprofloxacin derivatives with broad-spectrum antibacterial, MRSA and topoisomerase inhibitory activities.
    Aziz HA; El-Saghier AMM; Badr M; Abuo-Rahma GEA; Shoman ME
    Mol Divers; 2022 Jun; 26(3):1743-1759. PubMed ID: 34455532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel bis(pyrazole-benzofuran) hybrids possessing piperazine linker: Synthesis of potent bacterial biofilm and MurB inhibitors.
    Mekky AEM; Sanad SMH
    Bioorg Chem; 2020 Sep; 102():104094. PubMed ID: 32711085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Route to the Synthesis of Novel Pyrazolo[1,5-a]pyrimidines and Evaluation of their Antimicrobial Activity as RNA Polymerase Inhibitors.
    Abdallah AEM; Elgemeie GH
    Med Chem; 2022; 18(9):926-948. PubMed ID: 35236270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, antibacterial evaluation and docking study of novel 2-hydroxy-3-(nitroimidazolyl)-propyl-derived quinolone.
    Li Q; Xing J; Cheng H; Wang H; Wang J; Wang S; Zhou J; Zhang H
    Chem Biol Drug Des; 2015 Jan; 85(1):79-90. PubMed ID: 25048811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benzothiazole Clubbed Imidazolone Derivatives: Synthesis, Molecular Docking, DFT Studies, and Antimicrobial Studies.
    Desai N; Maheta A; Jethawa A; Ahmad I; Patel H; Dave B
    Curr Comput Aided Drug Des; 2023; 19(2):123-136. PubMed ID: 36411562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of 1H-1,2,3-Triazole-Linked Quinoline-Isatin Molecular Hybrids as Anti-Breast Cancer and Anti-Methicillin-Resistant Staphylococcus aureus (MRSA) Agents.
    Awolade P; Cele N; Ebenezer O; Kerru N; Gummidi L; Gu L; Palma G; Kaur M; Singh P
    Anticancer Agents Med Chem; 2021; 21(10):1228-1239. PubMed ID: 32990543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and biological evaluation of novel pleuromutilin derivatives possessing 4-aminothiophenol linker as promising antibacterial agents.
    Chai F; Wang J; Zhou KX; Wang SK; Liu YH; Jin Z; Tang YZ
    Bioorg Chem; 2022 Sep; 126():105859. PubMed ID: 35605553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.